FDA Inspection 1052466 — Peter Tenke, M.D., PhD, Principal Investigator
The FDA completed an inspection of Peter Tenke, M.D., PhD, Principal Investigator on Apr 13, 2018 in Budapest X. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 13, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Budapest X (Hungary)
Additional Details
Clinical Investigator (CI)